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A B S T R A C T
Background
This is an updated version of the original Cochrane Review published in the Cochrane Library, Issue 5, 2015.
Yoga may induce relaxation and stress reduction, and influence the electroencephalogram and the autonomic nervous system, thereby
controlling seizures. Yoga would be an attractive therapeutic option for epilepsy if proved effective.
Objectives
To assess whether people with epilepsy treated with yoga:
(a) have a greater probability of becoming seizure free;
(b) have a significant reduction in the frequency or duration of seizures, or both; and
(c) have a better quality of life.
Search methods
For this update, we searched the Cochrane Epilepsy Group Specialized Register (3 January 2017), the Cochrane Central Register of
Controlled Trials (CENTRAL; 2016, Issue 12) in the Cochrane Library (searched 3 January 2017), MEDLINE (Ovid, 1946 to 3
January 2017), SCOPUS (1823 to 3 January 2017), ClinicalTrials.gov (searched 3 January 2017), the World Health Organization
(WHO) International Clinical Trials Registry Platform (ICTRP) (searched 3 January 2017), and also registries of the Yoga Biomedical
Trust and the Research Council for Complementary Medicine. In addition, we searched the references of all the identified studies. No
language restrictions were imposed.
Selection criteria
The following study designs were eligible for inclusion: randomised controlled trials (RCT) of treatment of epilepsy with yoga. The
studies could be double-, single- or unblinded. Eligible participants were adults with uncontrolled epilepsy comparing yoga with no
treatment or different behavioural treatments.
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Data collection and analysis
Two review authors independently assessed the trials for inclusion and extracted data. The following outcomes were assessed: (a)
percentage of people rendered seizure free; (b) seizure frequency and duration; (c) quality of life. Analyses were on an intention-to-treat
basis. Odds ratio (OR) with 95% confidence intervals (95% Cls) were estimated for the outcomes.
Main results
We did not identify any new studies for this update, therefore the results are unchanged.
For the previous version of the review, the authors found two unblinded trials in people with refractory epilepsy. In total these two studies
included 50 people (18 treated with yoga and 32 to control interventions). Antiepileptic drugs were continued in all the participants.
Baseline phase lasted three months in both studies and treatment phase from five weeks to six months in the two trials. Randomisation
was by roll of a die in one study and using a computerised randomisation table in the other one but neither study provided details of
concealment of allocation and were rated as unclear risk of bias. Overall, the two studies were rated as low risk of bias (all participants
were included in the analysis; all expected and pre-expected outcomes were reported; no other sources of bias).
The overall ORs with 95% CI were as follows: (i) seizure free for six months - for yoga versus sham yoga the OR was 14.54 (95% CI
0.67 to 316.69) and for yoga versus ’no treatment’ group it was 17.31 (95% CI 0.80 to 373.45); for Acceptance and Commitment
Therapy (ACT) versus yoga the OR was 1.00 (95% Cl 0.16 to 6.42); (ii) reduction in seizure frequency - the mean difference between
yoga versus sham yoga group was −2.10 (95% CI −3.15 to −1.05) and for yoga versus ’no treatment’ group it was −1.10 (95% CI
−1.80 to−0.40); (iii) more than 50% reduction in seizure frequency - for yoga versus sham yoga group, OR was 81.00 (95% CI 4.36
to 1504.46) and for the yoga versus ’no treatment’ group it was 158.33 (95% CI 5.78 to 4335.63); ACT versus yoga OR was 0.78
(95% Cl 0.04 to 14.75); (iv) more than 50% reduction in seizure duration - for yoga versus sham yoga group OR was 45.00 (95% CI
2.01 to 1006.75) and for yoga versus ’no treatment’ group it was 53.57 (95% CI 2.42 to 1187.26); ACT versus yoga OR was 0.67
(95% Cl 0.10 to 4.35).
In addition in Panjwani 1996 the authors reported that the one-way analysis of variance revealed no statistically significant differences
between the three groups. A P-Lambda test taking into account the P values between the three groups also indicated that the duration
of epilepsy in the three groups was not comparable. No data were available regarding quality of life. In Lundgren 2008 the authors
reported that there was no significant difference between the yoga and ACT groups in seizure-free rates, 50% or greater reduction in
seizure frequency or seizure duration at one-year follow-up. The yoga group showed significant improvement in their quality of life
according to the Satisfaction With Life Scale (SWLS) (P < 0.05), while the ACT group had significant improvement in the World
Health Organization Quality of Life-BREF (WHOQOL-BREF) scale (P < 0.01).
Overall, we assessed the quality of evidence as low; no reliable conclusions can be drawn at present regarding the efficacy of yoga as a
treatment for epilepsy.
Authors’ conclusions
A study of 50 subjects with epilepsy from two trials reveals a possible beneficial effect in control of seizures. Results of the overall efficacy
analysis show that yoga treatment was better when compared with no intervention or interventions other than yoga (postural exercises
mimicking yoga). There was no difference between yoga and Acceptance and Commitment Therapy. However no reliable conclusions
can be drawn regarding the efficacy of yoga as a treatment for uncontrolled epilepsy, in view of methodological deficiencies such as
limited number of studies, limited number of participants randomised to yoga, lack of blinding and limited data on quality-of-life
outcome. Physician blinding would normally be taken to be the person delivering the intervention, whereas we think the ’physician’
would in fact be the outcome assessor (who could be blinded), so that would be a reduction in detection bias rather than performance
bias. In addition, evidence to inform outcomes is limited and of low quality. Further high-quality research is needed to fully evaluate
the efficacy of yoga for refractory epilepsy.
Since we did not find any new studies, our conclusions remain unchanged.
P L A I N L A N G U A G E S U M M A R Y
Yoga for epilepsy
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This review assessed the use of yoga as a treatment for control of epilepsy.
Background
Epilepsy is a disorder in which recurrent seizures are caused by abnormal electrical discharges in the brain. Most seizures can be controlled
by antiepileptic drugs (AEDs) but sometimes seizures develop which are resistant to those drugs. People may also wish to try non-drug
treatments such as yoga. Between 25% and 40% of people with epilepsy treated with AEDs have uncontrolled seizures, experience
adverse effects from medication, suffer from stigmatisation and have a higher degree of psychiatric disorders as compared with people
with other chronic illnesses. For those who have epilepsy and related problems it is important to develop, evaluate, and implement a
complementary treatment model in the everyday treatment of epilepsy.
Yoga, an integral part of Indian culture and heritage, is said to bestow good health physical, mental and spiritual on the practitioner.
There are various types of yoga involving postural exercises (asanas), breath control (pranayama) and meditation. In one study, the
practice of Sahaja yoga, a simple form ofmeditation, reduced seizures and EEG changes in people with epilepsy. The effect of meditation
was attributed to a reduction in the level of stress as evidenced by changes in skin resistance and levels of blood lactate and urinary
vanillylmandelic acid.
Results
For this update, we did not identify any new studies to add, and thus the conclusions remain unchanged. The review included two
unblinded randomised controlled trials (RCTs) recruiting a total of 50 participants (adults) with refractory epilepsy and comparing
any type of classical Indian yoga to the control groups receiving no intervention or interventions such as yoga-mimicking exercises
or Acceptance and Commitment Therapy. Antiepileptic drugs were continued in all the participants. The outcomes assessed were:
percentage of people rendered seizure free; seizure frequency and duration; and quality of life. Results of the overall efficacy analysis
show that yoga treatment was better when compared with no intervention or interventions other than yoga, but no reliable conclusions
can be drawn regarding the efficacy of yoga as a treatment for uncontrolled epilepsy. The yoga group showed significant improvement
in their quality of life according to the Satisfaction With Life Scale. Blinding may reduce the observer bias. Physician blinding may be
achieved with the outcomes being assessed by a physician who is not involved in the trial. Participant blinding may not be possible, since
it would be easy to distinguish whether the intervention given is yoga or not. It would be ideal if the seizure records are maintained by a
blinded observer. Seizure frequency outcomes should preferably be expressed as the proportion of individuals seizure free or proportion
with more than 50% reduction in seizure frequency, since mean values of seizure frequency are often skewed and difficult to analyse.
Seizure duration may be measured in seconds or minutes (per episode or month). Validated quality-of-life measures (disease specific)
may indicate whether there is overall improvement in the quality of life as a result of the intervention, besides seizure control.
Conclusions
No reliable conclusions can be drawn at present regarding the efficacy of yoga as a treatment for epilepsy. In addition, quality of the
evidence to inform outcomes is limited and of low quality. Yoga can be considered as a complex intervention, similar to other forms
of complementary and alternative treatments. Yoga can only be an add-on to AEDs at the present time and cannot be used as the sole
method of intervention. Finally, no reliable evidence was found to support the use of yoga and further trials are needed.
The evidence is current to 3 January 2017.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Yoga versus no yoga for uncontrolled epilepsy
Patient or population: people with epilepsy
Settings: outpat ients
Intervention: yoga
Comparison: no yoga
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No. of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
No yoga
(control)
Yoga
Seizure f ree (yoga ver-
sus sham yoga)2
0 per 1000 400 per 1000 OR 14.54
(0.67 to 316.69)
20
(1 study)
⊕⊕©©
low3,4
OR > 1 indicates out-
come is more likely on
Yoga
Seizure f ree (yoga ver-
sus none)2
0 per 1000 400 per 1000 OR 17.31
(0.8 to 373.45)
22
(1 study)
⊕⊕©©
low3,4
OR > 1 indicates out-
come is more likely on
Yoga
Seizure
f requency (yoga versus
sham yoga)
The mean seizure
f requency was 2.6
seizures per month (SD
1.58)
The mean seizure f re-
quency was −2.10
seizures per month
lower (95% CI −3.15 to
−1.05)
NA 20
(1 study)
⊕⊕©©
low3,4
Seizure f requency
(yoga versus none)
The mean seizure
f requency was 1.6
seizures per month (SD
1.03)
The mean seizure f re-
quency was −1.10
seizures per month
lower (95% CI −1.80 to
−0.40)
NA 22
(1 study)
⊕⊕©©
low3,4
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Greater than 50% re-
duct ion in seizure f re-
quency (yoga versus
sham yoga)
100 per 1000 800 per 1000
(226 to 894 per 1000)
OR 81
(4.36 to 1504.46)
20
(1 study)
⊕⊕©©
low3,4
OR > 1 indicates out-
come is more likely on
Yoga
Greater than 50% re-
duct ion in seizure f re-
quency (yoga versus
none)2
0 per 1000 900 per 1000 OR 158.33 (5.78 to
4335.63)
22
(1 study)
⊕⊕©©
low3,4
OR>1 indicates out-
come is more likely on
Yoga
Greater than 50% re-
duct ion in seizure dura-
t ion (yoga versus sham
yoga)2
0 per 1000 700 per 1000 OR 45.00
(2.01 to 1006.75)
20
(1 study)
⊕⊕©©
low3,4
OR > 1 indicates out-
come is more likely on
Yoga
Greater than 50% re-
duct ion in seizure dura-
t ion (yoga versus sham
yoga)2
0 per 1000 700 per 1000 OR 53.57
(2.42 to 1187.26)
22
(1 study)
⊕⊕©©
low3,4
OR > 1 indicates out-
come is more likely on
Yoga
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes1 . The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; OR: odds rat io.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1Assumed risk is calculated as the event rate in the control group per 1000 people (number of events divided by the number
of part icipants receiving control treatment).
2Assumed risk could not be calculated as no events occurred in the control group; therefore corresponding risk is est imated
as event rate in the intervent ion group per 1000 people.
3 In the study no blinding was achieved and it was rated as high risk of bias.
4 The study has wide conf idence intervals and, as a result , a wide conf idence interval of the pooled ef fect est imate, suggest ing
imprecision.
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B A C K G R O U N D
This review is an update of a previously published review in the
Cochrane Database of Systematic Reviews (Issue 5, 2015).
Description of the condition
Epilepsy is a condition characterised by a tendency for recurrent
seizures unprovoked by any known proximate insult. Epileptiform
discharges involve either a localised area of the brain resulting in a
partial seizure; or the entire brain resulting in a generalised seizure.
The prevalence of epilepsy is estimated to be five to eight per 1000
population in developed countries, and in adults the most com-
mon type is partial epilepsy (Forsgren 2005). The majority of peo-
ple given a diagnosis of epilepsy have a good prognosis, and their
seizures will be controlled by treatment with a single antiepileptic
drug (AED), but up to 30% do not have remission despite ap-
propriate therapy with AEDs (Kwan 2000). These people tend to
have frequent, disabling seizures that limit their ability to work
and participate in activities. Many of these people also suffer from
the chronic effects of long-term, high-dose AEDpolytherapy. Peo-
ple who have seizures more frequently have psychiatric disorders
like anxiety, depression and low quality of life as compared with
those with other chronic illness. The stigmatisation problems as-
sociated with epilepsy are well documented and can be linked to
a number of factors, including under-resourced medical seizures,
poor seizure control and inadequate knowledge of epilepsy (Jacoby
2002). The development of effective therapies for the treatment
of uncontrolled epilepsy is therefore of considerable importance.
Description of the intervention
Yoga is a traditional Indian discipline and way of life which gives
the practitioner a “healthy body and a sound mind” and is be-
lieved to alleviate stress and induce relaxation (Anand 1991).
The word ’yoga’ is probably derived from the Sanskrit word
’Yug’ which means ’controlling the mind’. The commonly per-
formed yogic practices include breathing exercises (pranayama),
postures (asanas), devotional sessions and meditation (dhyana).
Many branches of yoga have been described such as Hatha yoga,
Karma yoga, Bhakti yoga and Raja yoga. Transcendental Medi-
tation, which is widely practised, employs a single-stage medita-
tion during which the individual sits quietly with eyes closed for
20 minutes twice a day and mentally repeats a specifically chosen
Sanskrit word or mantra (Corby 1978). In Sahaja yoga, the practi-
tioners sit in a relaxed posture with hands in front, palms upwards.
They are asked to direct attention to a picture placed in front of
them, with a candle lit before it. Gradually when their thoughts
recede, they close their eyes and may direct their attention at the
’sahasrara chakra’ or top of the head. The individual sits in medi-
tation for about 10 to 15 minutes. It is believed that Sahaja yoga
awakens the kundalini (dormant divine energy in our body) and
corrects physical, mental and emotional disorders (Gupta 1991).
Sahaja yoga is a simple technique of meditation which is practised
easily by any individual, without the use of instruments. It has
been found beneficial for stress reduction in people with epilepsy
(Panjwani 1995).
How the intervention might work
Behavioural methods are currently being tried for seizure reduc-
tion since some people with epilepsy do not achieve seizure control
despite regular and adequate medication. Research suggesting that
behavioural treatments can influence the seizure process is substan-
tial (Lundgren 2006; Ramaratnam 2001). Yoga may induce relax-
ation and stress reduction, and influence the electroencephalogram
and the autonomic nervous system, thereby controlling seizures.
There are several reports regarding the use of yoga in psychiatric
disorders (Miller 1995; Nespoor 1993; Nespoor 1994), mental
retardation (Uma 1989), asthma (Goyeche 1980; Goyeche 1982;
Jain 1993a; Nagaratna 1985; Nagendra 1986; Singh 1990), re-
habilitation of myocardial infarct patients (Bulavin 1993), arthri-
tis (Garfinkel 1994; Haslock 1994), hypertension (Patel 1975;
Sundar 1984; Van Montfrans 1990), and other medical disor-
ders (Jain 1993b). The effect of yoga on the electroencephalo-
gram (Banquet 1973; Corby 1978; Dostalek 1979; Gastaut 1975;
Kugler 1982; Lerner 1975; Orme-Johnson 1988; Roldan 1983;
Roldan 1985; Satyanarayana 1992; Stancak 1991; Stancak 1994;
Surwillo 1978; Xu 1994; Zhang 1988) and on the autonomic
nervous system (Bhargava 1988; Telles 1993; Telles 1994; Telles
1995) have also been studied. Yoga has been demonstrated to in-
crease quality of life and decrease psychiatric problems for those
who have epilepsy (Yardi 2001). Stress is a well-recognised risk
factor for seizures in people with epilepsy (Temkin 1984); and
the efficacy of yoga in stress reduction has been documented
(Panjwani 1995; Schell 1994). There are also reports on the ef-
ficacy of biofeedback, relaxation and behaviour modification in
the treatment of epilepsy (Cabral 1976; Dahl 1985; Dahl 1987;
Dahl 1988; Puskarich 1992). Persinger 1993, based on a personal
philosophy interview of 221 university students practising medi-
tation, hypothesised that Transcendental Meditation and general
meditation (cognitive kindling) trigger “complex partial epileptic-
like signs” such as experience of vibrations, hearing one’s name
called, paranormal phenomena, etc. However, this view has been
strongly opposed by Orme-Johnson 1995 based on other studies
not quoted by Persinger. Yoga may have an effect on the probabil-
ity of seizure occurrence because of the effect it has on brain wave
activity and arousal level. Research shows that sudden changes in
cortical activity and arousal level affect the probability of seizure
occurrence. Other authors suggest that yoga training stimulates
the vagus nerve, and stimulation of the vagus nerve has been shown
to decrease seizure frequency by 28% to 38% (Brown 2005).
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Why it is important to do this review
For this review we summarise evidence from randomised con-
trolled trials where the efficacy of yoga has been investigated for
people with uncontrolled epilepsy. The aim was to evaluate the
effects of yoga on seizure frequency and on quality of life. Yoga
would be an attractive therapeutic option for epilepsy (if proven
effective) in view of its non-pharmacological nature, minimal ad-
verse effects and international acceptance.
O B J E C T I V E S
To assess whether people with epilepsy treated with yoga:
(a) have a greater probability of becoming seizure free;
(b) have a significant reduction in the frequency or duration of
seizures, or both; and
(c) have a better quality of life.
M E T H O D S
Criteria for considering studies for this review
Types of studies
In this review trials had to meet the following criteria.
1. Randomised controlled trials.
2. Parallel group or crossover studies.
3. Cluster or individual randomisation.
Types of participants
Eligible participants were people with all types of epilepsy, of all
age groups, and both genders.
Epileptic control group included people with all types of epilepsy,
of all age groups, and both genders, with no treatment or other
behavioural treatment.
Types of interventions
Any type of classical Indian yoga compared to the control group
receiving no intervention or interventions other than yoga, e.g.
muscle relaxation training or sham yoga or postural yoga-mim-
icking exercises or Acceptance and Commitment Therapy (ACT).
The use of antiepileptic drugs was permitted in both the treatment
and the control groups.
Types of outcome measures
The following outcome measures from the time of randomisation
to the completion of the study were analysed.
Primary outcomes
Seizure frequency
1. Number of individuals seizure free.
2. Number of seizures per month (mean per participant or per
group).
3. Number of individuals with more than 50% reduction in
seizure frequency.
4. Percentage change in seizure frequency.
Seizure duration
1. Seizure duration (minutes or seconds, per participant or per
group).
2. Number of individuals with more than 50% reduction in
seizure duration.
3. Percentage change in seizure duration.
Secondary outcomes
1. Improvement in the quality of life (if assessed by
standardised, reliable and valid instruments).
2. Dropout rates due to noncompliance or other reasons.
3. Reduction in dosage of anticonvulsants (yes or no).
Search methods for identification of studies
Electronic searches
For the previous version of the review, the authors searched the
following databases for relevant studies (Panebianco 2015).
(a) The Cochrane Epilepsy Group Specialized Register (searched
26 March 2015) using the search terms “yoga or relaxation or
meditation or pranayama or asanas”;
(b) Cochrane Central Register of Controlled Trials (CENTRAL;
2015, Issue 2) in the Cochrane Library (searched 26March 2015).
(c) MEDLINE Ovid (1946 to 26 March 2015).
(d) SCOPUS (searched 9 January 2014).
(e) US National Institutes of Health Ongoing Trials Register (
ClinicalTrials.gov; searched 26 March 2015).
( f ) The World Health Organization ( WHO) International Clin-
ical Trials Registry Platform ICTRP ( apps.who.int/trialsearch;
searched 26 March 2015).
(g) The registries of the Yoga Biomedical Trust, and Research
Council for Complementary Medicine.
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SCOPUS was searched as a substitute for Embase, but this is no
longer necessary, because randomised or quasirandomised con-
trolled trials in Embase are now included in CENTRAL. SCO-
PUS was therefore not included in the pre-publication search car-
ried out on 26 March 2015.
For this update, we searched the following databases for relevant
studies.
(a) The Cochrane Epilepsy Group Specialized Register (searched
3 January 2017) using the search terms “yoga or relaxation or
meditation or pranayama or asanas”, using the strategy outlined
Appendix 1.
(b) Cochrane Central Register of Controlled Trials (CENTRAL;
2016, Issue 12) in the Cochrane Library (searched 3 January
2017), using the strategy outlined in Appendix 2.
(c) MEDLINE Ovid (1946 to 3 January 2017), using the strategy
outlined in Appendix 3.
( d) US National Institutes of Health Ongoing Trials Register (
www.clinicaltrials.gov; searched 3 January 2017), using the strat-
egy outlined in Appendix 4.
( e) The World Health Organization ( WHO) International Clin-
ical Trials Registry Platform ICTRP ( apps.who.int/trialsearch;
searched 03 January 2017), using the strategy outlined in
Appendix 5.
(f ) The registries of the Yoga Biomedical Trust, and Research
Council for Complementary Medicine.
SCOPUS was searched as a substitute for Embase, but this is no
longer necessary, because randomised or quasirandomised con-
trolled trials in Embase are now included in CENTRAL. SCO-
PUS was therefore not included in the pre-publication search car-
ried out on 3 January 2017.
We imposed no language restrictions. We tailored searches to in-
dividual databases, and adapted from those used in the previous
review.
Searching other resources
For the previous review and this update, we reviewed reference
lists of included studies to search for additional reports of relevant
studies. We also contacted the members of the Neurological So-
ciety of India through the newsletter of the Society to seek any
completed (unpublished or published) or ongoing studies. Letters
or e-mails were sent to several neurophysiology institutions, yoga
institutes and yoga experts in India as well as outside India, to find
out any studies (unpublished or published in non-indexed jour-
nals) regarding the treatment of epilepsy with yoga. The abstracts
were independently perused by two review authors (SR and KS),
to assess their relevance for inclusion in the review. Cross-refer-
ences were obtained from the relevant identified articles.
Data collection and analysis
Selection of studies
For this update, two review authors (MP and SR) independently
assessed trials for inclusion. We resolved any disagreements by
discussion with a third author (KS). Two review authors (MP and
SR) independently extracted data and assessed the risk of bias for
included trials; again disagreements were resolved by discussion.
Data extraction and management
We extracted the following data for each trial using a data extrac-
tion form.
(I) Methodological/trial design
1. Method of randomisation.
2. Method of allocation concealment.
3. Method of double blinding.
4. Whether any participants had been excluded from reported
analyses.
5. Duration of baseline period.
6. Duration of treatment period.
7. Duration of follow-up.
8. Information on sponsorship/funding.
(II) Participant/demographic information
1. Number of participants allocated to each treatment group
(total per group).
2. Age and gender distribution.
3. Type of epilepsy.
4. Duration of epilepsy.
5. Aetiology of epilepsy.
6. Type of intervention.
(III) Outcomes
We recorded the number of participants experiencing each out-
come per randomised group (see Types of outcome measures). We
contacted authors of trials for any missing information.
Assessment of risk of bias in included studies
Two review authors (MP and SR) independently assessed the risk
of bias for each trial using the Cochrane ’Risk of bias’ tool as
described in the Cochrane Handbook for Systematic Reviews of In-
terventions (Higgins 2011). We discussed and resolved disagree-
ments. We completed a ’Risk of bias’ table for each included study
in Review Manager 5 (RevMan 5). Included studies were rated as
low, high or unclear risk of bias on six domains applicable to ran-
domised controlled trials: randomisation method, allocation con-
cealment, blinding methods, incomplete outcome data, selective
outcome reporting, and other sources of bias. We created ’Sum-
mary of findings’ tables using GRADEpro and the GRADE ap-
proach for assessing the quality of evidence (Schünemann 2013).
Measures of treatment effect
The primary outcomes of seizure frequency and seizure duration
were analysed as a binary outcome and presented as odds ratios
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(ORs). Mantel-Haenszel ORs and 95% confidence intervals (CIs)
are estimators for categorical data such as the proportion of indi-
viduals seizure free or 50% responders, while the mean difference
(MD) and 95% CI may be used for continuous data such as mean
seizure frequency. We planned to analyse the secondary outcomes,
including quality of life, treatment withdrawal and reduction in
antiepileptic drug (AED), as continuous outcomes and present
them using the standardised mean difference. However, this was
not possible (different definitions of outcomes were employed so
data could not be pooled) and therefore we have discussed these
outcomes narratively.
Unit of analysis issues
We encountered no unit of analysis issues as we found no crossover
studies. All studies were randomised at an individual level so we
included no cluster randomised studies and data were not of a
longitudinal design. We analysed all outcomes as ORs as planned,
or discussed narratively.
Dealing with missing data
We sought any missing data from the study authors. We present
all analyses in the main report.
Assessment of heterogeneity
Clinical heterogeneity was not applicable, because we were unable
to pool findings from studies. Clinical heterogeneity should be
assessed by comparing the distribution of important individual
participant factors among trials (for example age, seizure type, du-
ration of epilepsy, number of AEDs taken at the time of randomi-
sation) and trial factors (for example randomisation concealment,
blinding, losses to follow-up).
Assessment of reporting biases
We requested all protocols from study authors to enable a compar-
ison of outcomes of interest. If we had suspected outcome report-
ing bias for any included study, we planned to further investigate
using the ORBIT matrix system (Kirkham 2010). We planned to
examine funnel plot asymmetry to establish publication bias; how-
ever such an assessment was not possible due to the small number
of studies included in the review.
Data synthesis
We employed a fixed-effect model meta-analysis to synthesise the
data. Comparisons we expected to carry out included:
1. intervention group (yoga) versus controls on seizure free;
2. intervention group (yoga) versus controls on seizure
frequency;
3. intervention group (yoga) versus controls on greater than
50% reduction in seizure frequency;
4. intervention group (yoga) versus controls on greater than
50% reduction in seizure duration.
We stratified each comparison by type of control group and study
characteristics to ensure the appropriate combination of study
data. We calculated ORs with 95% Cl for the categorical data;
and MD with 95% CI for continuous data.
Subgroup analysis and investigation of heterogeneity
We planned to undertake subgroup analysis for study, participant
characteristics, outcomes, etc. We intended to investigate hetero-
geneity using sensitivity analysis if we deemed it appropriate.
Sensitivity analysis
We also intended to carry out sensitivity analysis if we found pe-
culiarities between study quality, participants’ characteristics, in-
terventions and outcomes.
R E S U L T S
Description of studies
Results of the search
The latest search (carried out 3 January 2017) identified 15 records
from the databases outlined above.We screened8 records for inclu-
sion in the review after removing duplicates and irrelevant items.
We excluded 3 records at this point, and requested five full-text
articles to assess for eligibility. We contacted authors of these trials
for more information providing their contact details were avail-
able. Following this, we excluded 4 studies (please see Figure 1
and Characteristics of excluded studies for reasons of exclusion).
We identified one study as ongoing (see Characteristics of ongoing
studies). Thus, no new studies were included in this review.
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Figure 1. Study flow diagram
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Included studies
We did not find any new studies for this update. In the previous
version of this review, the authors included two randomised con-
trolled trials which recruited a total of 50 participants with un-
controlled epilepsy (Lundgren 2008; Panjwani 1996). Trial char-
acteristics are summarised below; for further information on each
trial please see Characteristics of included studies.
One single centre trial investigated 18 subjects aged 18 to 55
years with uncontrolled epilepsy, and had two treatment arms: Ac-
ceptance and Commitment therapy (ACT); and yoga (Lundgren
2008). Antiepileptic drugs (AEDs) were continued in both groups.
This trial had a baseline period of three months and a treatment
period of five weeks. Dahl 2005 is linked to this study.
Another single centre trial randomised 32 subjects aged 15 to 35
years with drug-resistant epilepsy to one of three treatment arms:
Sahaja yoga (group I); exercises mimicking Sahaja yoga (group II);
and control group without any intervention (group III) (Panjwani
1996). AEDs were continued in all three groups. This trial had
a baseline period of three months and a treatment period of six
months. Themean age,mean duration of epilepsy and the baseline
seizure frequencies at the time of recruitment to the study were
lower in group III (’no treatment’ control) compared to groups I
(Sahaja yoga) and II (sham yoga). We contacted the author of this
study for additional data not available in the publication, i.e. de-
tails of the randomisation procedure, and details of outcome mea-
sures not included in the publication (including the number of
individuals with more than a 50% reduction in seizure frequency
and number of individuals with more than a 50% reduction in
seizure duration in each group). The author provided some addi-
tional data regarding this study. Panjwani 2000 is linked to this
study.
Excluded studies
In this update, we excluded 4 studies for the following reasons:
one study was not randomised; two studies did not use yoga as
an intervention; one study provided insufficient information. For
further information on each trial please see Characteristics of
excluded studies.
Risk of bias in included studies
See Figure 2 and Figure 3 for a summary of the risk of bias in each
included study. Each study was allocated an overall rating for risk
of bias. All studies included in the review were individually rated
as low risk of bias or high risk of bias or unclear risk of bias. See
below for specific domain ratings.
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
Allocation
In both Lundgren 2008 and Panjwani 1996, the methods by
which allocation was concealed was rated as unclear risk of bias.
The two trials did not provide details of concealment of alloca-
tion. As for the domain of sequence generation, both studies were
rated as low risk of bias (Lundgren 2008; Panjwani 1996). In the
Lundgren 2008 study randomisation was generated using a com-
puterised randomisation table. The randomisation procedure in
the Panjwani 1996 trial was by rolling dice.
Blinding
In both studies included, no blinding was achieved by using yoga
treatment and they were rated as high risk of bias on this particular
domain (Lundgren 2008; Panjwani 1996). This could limit the
validity of the observed treatment effects.
Incomplete outcome data
Both studies were rated as low risk of bias because all participants
were included in the analysis (Lundgren 2008; Panjwani 1996).
Selective reporting
In both studies selective reporting was rated as low risk of bias
due to all expected and pre-specified outcomes being reported in
each of the publications (Lundgren 2008; Panjwani 1996). The
protocols were not available when requested to compare a priori
methods and outcomes to the published report.
Other potential sources of bias
Both studies appeared to be free of other sources of bias and were
therefore rated as low risk of bias on this domain.
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Effects of interventions
See: Summary of findings for the main comparison; Summary
of findings 2
See: Summary of findings for the main comparison, Summary of
findings 2.
(a) Seizure frequency
1. Number of participants seizure free
In the Panjwani 1996 study, 4 out of the 10 participants given
Sahaja yoga were seizure free for the duration of the six months’
treatment period, compared to none out of 10 in the sham yoga
group and none out of 12 in the ’no treatment’ control group.
This gives odds ratios (ORs) with 95% confidence intervals (Cls)
of 14.54 (95% CI 0.67 to 316.69) for the yoga versus sham yoga
groups; and 17.31 (95% CI 0.80 to 373.45) for yoga versus ’no
treatment’ control groups (see Analysis 1.1; Figure 4).
Figure 4. Forest plot of comparison: 1 Yoga versus no yoga, outcome: 1.1 Seizures six months after
treatment.
In the Lundgren 2008 study, comparing Acceptance and Com-
mitment Therapy (ACT) versus yoga, 5 of the 10 participants in
the ACT group and 4 of the 8 participants in the yoga group were
seizure free at the end of the trial (12-month follow-up). This gives
ORs with 95% CIs of 1.00 (95% CI 0.16 to 6.42) for yoga versus
ACT (see Analysis 2.1; Figure 5).
Figure 5. Forest plot of comparison: 2 Yoga versus Acceptance Commitment Therapy (ACT), outcome: 2.1
Seizure free at 1 year follow-up.
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2. Reduction in seizure frequency
In the Panjwani 1996 trial the number of seizures per month in
the three different groups are shown in Table 1. Control group III
(no treatment) has differing baseline seizure frequency compared
to groups I and II which is statistically significant (group I versus
group III t = 2.25, P = 0.043). The mean difference (95% CIs in
seizure frequency after six months) for group I (Sahaja yoga) versus
group II (sham yoga) was −2.10 (95% CI −3.15 to −1.05) and
for group I versus group III −1.10 (95% CI −1.80 to −0.40).
The reduction in seizure frequency in group I was found to be
statistically significant (P < 0.001) compared to the baseline fre-
quency (0 month) (see Analysis 1.2; Figure 6).
Figure 6. Forest plot of comparison: 1 Yoga versus no yoga, outcome: 1.2 Seizure frequency (number per
month).
3. More than 50% reduction in seizure frequency
In the Panjwani 1996 study more than 50% reduction in seizure
frequency was found in 9 out of the 10 participants practising
Sahaja yoga but only in 1 out of the 10 on sham yoga and none of
the 12 untreated controls. This gives ORs of 81.00 (95% CI 4.36
to 1504.46) and 158.33 (95% CI 5.78 to 4335.63) respectively
(see Analysis 1.3; Figure 7).
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Figure 7. Forest plot of comparison: 1 Yoga versus no yoga, outcome: 1.3 Greater than 50% reduction in
seizure frequency - six months.
Lundgren 2008, comparing ACT versus yoga, found 50% or
greater reduction in seizure frequency in 9 of 10 participants in
the ACT group and 7 of 8 participants in the yoga group. This
gives ORs of 0.78 (95% Cl 0.04 to 14.75) for yoga versus ACT
(see Analysis 2.2; Figure 8).
Figure 8. Forest plot of comparison: 2 Yoga versus Acceptance Commitment Therapy (ACT), outcome: 2.2
50% or greater reduction in seizure frequency.
(b) Seizure duration
1. Greater than 50% reduction in seizure duration after six
months
In Panjwani 1996, seven participants given Sahaja yoga had more
than 50% reduction in seizure duration compared to none among
the two control groups. This gives ORs of 45.00 (95% CI 2.01
to 1006.75) for group I versus group II; and 53.57 (95% CI 2.42
to 1187.26) for group I versus group III respectively (see Analysis
1.4; Figure 9).
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Figure 9. Forest plot of comparison: 1 Yoga versus no yoga, outcome: 1.4 Greater than 50% reduction in
seizure duration - six months.
In the Lundgren 2008 trial 6 of 10 participants in the ACT group
and 4 of 8 in the yoga group had 50% or greater reduction in
seizure duration at the end of one year. This gives ORs of 0.67
(95% Cl 0.10 to 4.35) for yoga versus ACT (see Analysis 2.3;
Figure 10).
Figure 10. Forest plot of comparison: 2 Yoga versus Acceptance Commitment Therapy (ACT), outcome:
2.3 50% or greater reduction in seizure duration.
(c) Quality of Life (pretest to post-test)
In Lundgren 2008 the World Health Organization Quality of
Life-BREF (WHOQOL-BREF) revealed significant improve-
ment among the participants in the ACT group (P < 0.01), but the
changes on Satisfaction With Life Scale (SWLS) over time were
not significant. The participants in the yoga group had significant
improvement in their quality of life according to the SWLS (P
< 0.05), but did not show any significant changes in the WHO-
QOL-BREF.
No data were available in the Panjwani 1996 study regarding this
outcome. The author concludes that a changed lifestyle with re-
duction in stressmay be an important factor contributing to seizure
reduction and EEG changes following Sahaja yoga.
(d) Dropout rates due to noncompliance or other reasons
Included studies did not report this outcome.
(e) Reduction in dosage of AED
Included studies did not report this outcome.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Yoga versus Acceptance and Commitment Therapy (ACT) for uncontrolled epilepsy
Patient or population: people with epilepsy
Settings: outpat ients
Intervention: yoga
Comparison: Acceptance and Commitment Therapy (ACT)
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No. of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
ACT Yoga
Seizure f ree at 1 year
follow-up
500 per 1000 500 per 1000
(138 to 865 per 1000)
OR 1.00
(0.16 to 6.42)
18 (1 study) ⊕⊕©©
low1,2
OR > 1 indicates out-
come is more likely on
yoga
50% or greater reduc-
t ion in seizure f re-
quency
900 per 1000 702 per 1000
(265 to 993 per 1000)
OR 0.78
(0.04 to 14.75)
18 (1 study) ⊕⊕©©
low1,2
OR > 1 indicates out-
come is more likely on
yoga
50% or greater reduc-
t ion in seizure durat ion
600 per 1000 402 per 1000
(130 to 867 per 1000)
OR 0.67
(0.10 to 4.35)
18 (1 study) ⊕⊕©©
low1,2
OR > 1 indicates out-
come is more likely on
yoga
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes.3 The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
ACT: Acceptance and Commitment Therapy; CI: conf idence interval; OR: odds rat io.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1
7
Y
o
g
a
fo
r
e
p
ile
p
sy
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
7
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
1 In the study no blinding was achieved and it was rated as high risk of bias.
2 The study has wide conf idence intervals and, as a result , a wide conf idence interval of the pooled ef fect est imate, suggest ing
imprecision.
3 Assumed risk is calculated as the event rate in the control group per 1000 people (number of events divided by the number
of part icipants receiving control treatment).
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
1
8
Y
o
g
a
fo
r
e
p
ile
p
sy
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
7
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
D I S C U S S I O N
Summary of main results
Since publication of the previous version of this review, we found
no new studies that met the selection criteria for this review.
In the previous review, only two studies met the selection criteria.
We were not able to combine the results of the two studies, since
the comparison arms were different. In these randomised con-
trolled trials the number of individuals treated was small. These
methodological flaws make the results very difficult to interpret.
In the Panjwani 1996 study the authors reported that the one-way
analysis of variance revealed no statistically significant differences
between the three groups. However, by a modified t-test the dif-
ferences were found to be statistically significant between group
I and group III, both for seizure duration (t = 2.457, P = 0.023)
and seizure frequency (t = 2.247, P = 0.043). A P-Lambda test
taking into account the P values between the three groups also
indicated that the duration of epilepsy in the three groups was not
comparable. No data were available regarding quality of life. In
Lundgren 2008 the authors reported that there was no significant
difference between the yoga and ACT groups in seizure-free rates:
50% or greater reduction in seizure frequency or seizure duration
at one year follow-up. The yoga group showed significant improve-
ment in their quality of life according to the SatisfactionWith Life
Scale (SWLS) (P < 0.05), while the Acceptance and Commitment
Therapy (ACT) group had significant improvement in the World
Health Organization Quality of Life-BREF (WHOQOL-BREF)
scale (P < 0.01).
Overall completeness and applicability of
evidence
Only two studies look at yoga for epilepsy with 50 participants
in total. The participants would be those whose seizures are not
controlled with AEDs alone or those who require high doses of
AEDs with attendant side effects. Individuals who are not suitable
for epilepsy surgery and those who refuse further attempts to find
a successful medical therapy may also be candidates for a trial of
yoga. Individuals with single seizure or infrequent seizures are un-
likely to be suitable candidates since it is difficult to demonstrate a
treatment effect in them. The participants should have sufficient
time and motivation to continue yoga on a daily basis. They must
have sufficient time to commute to the centre for learning yoga,
which may be almost daily in the initial stages, and subsequently
practise yoga for a minimum of 20 to 30 minutes daily at home.
The number of participants enrolled should be sufficient to allow
reliable conclusions. There may be a need for a multi-centre study
to recruit a sufficient number of participants. In case of a multi-
centre study, it would be essential to standardise the interventions.
Enrolling individuals from different cultural backgrounds will al-
low investigation of the effect of cultural bias. It needs to be as-
certained whether the participants’ inherent belief in yoga or the
skills and personality of the yoga instructor contribute to the out-
come. Serum levels of AEDs need to be monitored to ensure that
the observed results are not due to the variation in serum levels of
AEDs. Consent for randomisation to a placebo-controlled study
may be difficult, leading to refusal to participate in the study, more
so if the controls have to report to the centre at the same time as
the intervention group and go back without receiving any treat-
ment. To overcome this, financial incentives may need to be given
to the participants. It is possible that the individuals receiving fi-
nancial incentives may try to please the co-ordinator of the study
with favourable results. Alternatively, the controls may be given
the intervention after the study period is over (deferred treatment
group). It may be difficult to ensure the compliance of the person
(whether he or she practises yoga at home regularly).
Quality of the evidence
Type of participants and interventions: The following contro-
versial issues in participant selection and intervention need to be
addressed.
1. Can any modifications be made to AEDs during the period
of study? If so, it may be difficult to assess whether the beneficial
results are due to the intervention or due to changes in the
medical treatment. It may be preferable to include only
individuals whose AED regimen has been stable and is unlikely
to require modifications during the study period.
2. Which type of seizures or epilepsy to choose for the study?
Should people with any type of epilepsy be included or
individuals with a specific homogenous syndrome such as
juvenile myoclonic epilepsy be chosen? It may be difficult to
recruit sufficient numbers of individuals if the study is confined
to a specific type of seizure or epilepsy syndrome.
3. Which type of yoga to use? There are many types of yoga.
The existing studies have utilised Sahaja yoga, Hatha yoga and
Transcendental Meditation. Until more data are available, the
choice of the type of yoga used as an intervention is likely to be
empirical.
4. What interventions should be given to controls? If no
intervention is given to controls, it will be difficult to decide if
the benefit is due to the intervention itself or due to the
additional attention given to the yoga group (attention bias).
Hence it may be necessary to have an attention control group by
giving sham yoga or exercises mimicking yoga. Even if the
controls are asked to come and sit quietly in one place, the
accompanying relaxation may give beneficial results.
5. Should participants be used as their own controls and the
seizure frequency before and after intervention be compared?
This would be an additional outcome measure, though subject
to bias.
A cross-over study will be difficult since individuals may continue
with yoga even after completion of the treatment phase.
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Methods: Randomisation is essential to eliminate selection bias.
The ideal method would be by telephone with computer-gener-
ated random lists. Consecutively numbered, sealed opaque en-
velopes would be less expensive, although it is possible that they
may be prematurely opened and a bias introduced. Blinding may
reduce the observer bias. Physician blinding may be achieved with
the outcomes being assessed by a physician who is not involved in
the trial. Participant blinding may not be possible, since it would
be easy to distinguish whether the intervention given is yoga or
not. It would be ideal if the seizure records are maintained by a
blinded observer. It would require a lot of co-operation from the
individual not to disclose the nature of intervention to the ob-
server, who in most cases would be a parent or spouse or a close
family member.
Outcome measures: Reliable maintenance of seizure records will
require a close family member, since the individual may not be
aware of the episodes. Records of seizure frequency may be in-
accurate since seizures occurring during sleep or abortive seizures
occurring when the individual is outdoors may not be recorded.
Seizure frequency outcomes should preferably be expressed as the
proportion of individuals seizure-free or the proportion with more
than 50% reduction in seizure frequency, since mean values of
seizure frequency are often skewed and difficult to analyse.
Seizure duration may be measured in seconds or minutes (per
episode or month). Validity of records of seizure duration main-
tained by unblinded observers may be questioned. Seizure severity
scales may be more sensitive indicators of a treatment effect than
seizure frequency data. Validated quality of life measures (disease
specific) may indicate whether there is overall improvement in
quality of life as a result of the intervention, besides seizure con-
trol. Dropouts from the study may cause an attrition bias. The
reason for dropout, e.g. whether it is due to lack of efficacy or time
constraints or lack of motivation, would be helpful in assessing
the true efficacy.
Analysis: The type of analysis that should be undertaken is con-
troversial. An intention-to-treat analysis includes all participants
allocated to an intervention, irrespective of whether they actually
followed the intervention or not. This would give a pragmatic es-
timate of the benefit, if a policy is taken to implement the inter-
vention for treatment of epilepsy rather than the potential bene-
fit in individuals who receive treatment exactly as planned. A per
protocol analysis may overestimate the actual efficacy of the inter-
vention. When the reason for dropout from the study is not clear,
a worst case and best case scenario can be calculated based on the
following assumptions: (a) all those not completing the follow-up
are non-responders in the intervention group and responders in
the control group (worst case); and (b) individuals not complet-
ing the follow-up are responders in the intervention group and
non-responders in the control group (best case). Mantel-Haenszel
odds ratios and 95% confidence intervals (CIs) are estimators for
categorical data such as the proportion of individuals seizure-free
or 50% responders, while the mean difference and 95% CI may
be used for continuous data such as mean seizure frequency.
Potential biases in the review process
Although we requested all protocols, the time frame in which the
majority of the studies were conducted made retrieval of all of
these difficult. This could lead to potential bias through omitted
information we did not have access to.
Agreements and disagreements with other
studies or reviews
Despite the study by Deepak 1994 containing a detailed analysis
of the results, we decided to exclude it primarily for lack of an
acceptable method of randomisation. Deepak 1994 included peo-
ple with “very frequent seizures” while Panjwani 1996 included
individuals with “not so frequent seizures” and hence even if the
former study had been included, we could not have combined the
results of the two studies.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
No reliable conclusions can be drawn at present regarding the
efficacy of yoga as a treatment for epilepsy. The complexity of
the yoga intervention is similar to other forms of complementary
and alternative treatments. Yoga may be an add-on to antiepileptic
drugs (AEDs) at the present time and cannot be used as the sole
method of intervention.
Implications for research
The addition of further evidence from future studies may change
the results and conclusions of this review.
Further research is needed, as follows.
• The trials should describe the details of the inclusion and
exclusion criteria (the age and sex distribution of the participants
enrolled, age at onset of epilepsy, duration of epilepsy, type of
epilepsy, aetiology of epilepsy, presence or absence of mental
retardation, progressive neurological disease, psychopathology,
co-existing hysterical seizures, and whether they were on
medication appropriate to the type of epilepsy in adequate doses
as determined by serum levels); the details of the intervention
given and how the AED therapy was handled during the study
period need to be elaborated.
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• A study with a much larger number of participants is
needed to clarify the efficacy or lack of efficacy of yoga in the
treatment of epilepsy. Centres which evaluate large numbers of
people with uncontrolled epilepsy and centres performing
epilepsy surgery could set up a randomised controlled trial to
evaluate the efficacy of yoga in the treatment of epilepsy. The
number of participants enrolled should be sufficient to allow
reliable conclusions.
• The trials should have an attention control group by giving
sham yoga or exercises mimicking yoga.
• The trials should have an ideal of randomisation (by
telephone with computer generated random lists). Physician
blinding may be achieved with the outcomes being assessed by a
physician who is not involved in the trial. Participant blinding
may not be possible, since it would be easy to distinguish
whether the intervention given is yoga or not. It would be ideal if
the seizures’ records are maintained by a blinded observer. It
would require a lot of co-operation from the individual not to
disclose the nature of intervention to the observer, who in most
cases would be a parent or spouse or a close family member.
• A study with a validated quality-of-life measure (disease
specific) may indicate whether there is overall improvement in
the quality of life as a result of the intervention, besides seizure
control.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Lundgren 2008
Methods Randomised controlled study.
Pre-randomisation baseline period: 3 months.
Duration of treatment phase: 5 weeks and booster sessions at 6 and 12 months post-
treatment
Study setting: hospital outpatient clinic.
Participants A single centre study (India).
18 adults with refractory epilepsy, minimum seizure frequency of 3 episodes in past 3
months. People with progressive illness were excluded
The subjects were randomly divided into two groups.
• Group I (N = 10, 3 women and 7 men): treated with ACT.
• Group II (N = 8, 3 women and 5 men): treated with received yoga.
The mean age in group I was 21.9 years, while in group II it was 25.8 years
Both groups continued to receive anticonvulsants.
Interventions Randomised comparison of ACT (group I) and yoga (group II) in subjects with drug-
refractory seizures
Yoga included Pranayama (’controlled deep breathing’), Asanas (’physical postures’),
and Dhyana (’meditation’), Yama (’harmony with others’) and Niyama (’harmony with
yourself ’). ACT was given in 2 sessions (individual session and group session)
The treatment protocols consisted of 12 hours of professional therapy distributed in 2
individual sessions, 2 group sessions during a 5-week period, and booster sessions at 6
and 12 months post-treatment
Outcomes Therapeutic effects were measured using: ’seizure index’ (seizure frequency × seizure
duration); and quality of life (Satisfaction With Life Scale (SWLS); and World Health
Organization Quality of Life instrument, short version (WHOQOL-BREF))
Seizure index was assessed during 3-month baseline and 12-month follow-up using a
seizure diary. Quality of life was measured prior to the initiation of treatment, after
treatment, and at the 6-month and 12-month follow-ups
Notes DAHL 2005 Epilepsia is linked to this study.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computerised randomisation table.
Allocation concealment (selection bias) Unclear risk No details of concealment of allocation.
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Lundgren 2008 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
High risk No blinding because is not applicable with
participants and yoga instructor. Outcome
assessors not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants were included in the anal-
ysis.
Selective reporting (reporting bias) Low risk Included all pre-specified expected out-
comes.
Other bias Low risk This study appeared to be free of other
sources of bias.
Panjwani 1996
Methods Randomised controlled trial of 32 individuals with uncontrolled epilepsy
Pre-randomisation baseline period: 3 months.
Duration of treatment phase: 6 months; this period included 0-, 3-, 6-month time-
points.
Study setting: hospital epilepsy clinic.
Participants A single centre study (India).
32 adults with clinical diagnosis of idiopathic epilepsy and minimum seizure frequency
of 4 episodes in past 3 months
The subjects were randomly divided into three groups.
• Group I (N = 10, 9 women and 1 man) received Sahaja yoga.
• Group II (N = 10, 9 women and 1 man) received exercises mimicking Sahaja yoga.
• Group III (N = 12, all women) received no additional intervention.
The mean (± SD) age in group I was 24.6 ± 6.6 years, while in groups II and III it was
23.7 ± 7.9 years and 19.7 ± 4.8 years respectively. The mean duration of illness (± SD)
was 7.3 ± 3.5 years in group I; 5.6 ± 2.8 in group II; and 4.2 ± 2.4 in group III
All groups continued to receive anticonvulsants.
Interventions Randomised comparison of Sahaja yoga (group I), received exercises mimicking Sahaja
yoga (group II), and without any intervention (group III)
The intervention group reported to the department on all working days for the first
month and thereafter twice a week for the remaining study period (6 months) and
practised Sahaja yoga twice daily for 20 to 30 minutes, under the guidance of a trained
instructor. Group II participants were providedwith the same environment and attention
as group I, but did not practice meditation. Group III participants were followed up in
the neurological outpatient clinic
Outcomes Therapeutic effects were measured using: ’seizure frequency’ (expressed as attacks per
month), noted for 3 months prior to enrolment in the study (0 month), and at 3 and
6 months of the study; and EEG (routine recording was scanned for the presence of
epileptiform activity) was recorded at 0, 3 and 6 months
Seizure data collection was based on weekly interviews with the participant and his/her
accompanying relative
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Panjwani 1996 (Continued)
Notes PANJWANI 2000 Applied Psychophysiology and Biofeedback is linked to this study.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation by roll of the dice.
Allocation concealment (selection bias) Unclear risk No details of concealment of allocation.
Blinding (performance bias and detection
bias)
All outcomes
High risk No blinding because is not applicable with
participants and yoga instructor. Outcome
assessors not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants were included in the anal-
ysis.
Selective reporting (reporting bias) Low risk Included all pre-specified expected out-
comes.
Other bias Low risk This study appeared to be free of other
sources of bias.
ACT: Acceptance and Commitment Therapy
EEG: electroencephalogram.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Arias 2006 Ineligible population (people with no epilepsy).
Bleichhardt 2004 Ineligible population (people with no epilepsy).
Büssing 2012 This is a review and not a randomised study.
Chander 2015 No yoga treatment.
CTRI/2010/091/001072 No yoga treatment (reflexology therapy).
Deepak 1994 This is an old abstract. It is not clear if it is a randomised controlled trial and did not report the results.We
attempted to clarify with the author regarding the randomisation and the results, but have not received
any reply so far
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Dudani 1989 This is an old conference abstract and it was not possible to contact the authors for details regarding
randomisation procedure and the outcomes data
Elsas 2011 No yoga treatment.
Fenwick 1994 No yoga treatment.
Gupta 1991 This is an open study, no control group, no randomisation or blinding
Jaseja 2006A Not an RCT.
Jaseja 2006B Not an RCT.
Lidbeck 1997 Ineligible population (people with no epilepsy) and no yoga treatment
McCall 2013 This is a review and not a randomised study.
Meyer 2012 This is a review and not a randomised study.
Nadkarni 1997 The author was contacted for details regarding the randomisation procedure and the outcomes data. At
the time of writing this review update, no response had been received from the author
Nanke 2000 Ineligible population (people with no epilepsy).
Nanke 2003 Ineligible population (people with no epilepsy).
NCT00179452 2003 This is a non-randomised study.
NCT00370929 2006 This is a non-randomised study.
Polak 2012 No yoga treatment.
Privitera 2014 This is a non-randomised study.
Privitera 2015 This is an abstract and did not report the results. We attempted to clarify with the author, but have not
received any reply so far
Rajesh 2006 This is a non-randomised study.
Ramaratnam 2001 Not an RCT.
Ricotti 2006 No yoga treatment.
Rousseau 1985 This is an old paper and it was not possible to contact the authors for details regarding randomisation
procedure and the outcomes data
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Sathyaprabha 2005 The study investigates the effect of yoga on autonomic dysfunction among people with refractory epilepsy.
Effects on seizure frequency do not appear to be the primary outcome investigated. Allocation was by
alternation
Saxena 2011 This is a review and not a randomised study.
Shigaki 2006 Ineligible population (people with no epilepsy) and no yoga treatment
Snyder 1983 No yoga treatment.
Sonnen 1972 This is a non-randomised study.
Thompson 2010 No yoga treatment.
Thompson 2015 No yoga treatment.
Timmer 2004 Ineligible population (people with no epilepsy).
Whitman 1990 No yoga treatment.
Yardi 2001 This is a non-randomised study.
Öst 1987 This is a review and not a randomised study.
Characteristics of ongoing studies [ordered by study ID]
NCT02950636 2016
Trial name or title Effect of Yoga on mood and quality of life in patients with refractory epilepsy
Methods Randomised controlled trial.
Participants The study population will consist of people (aged 18 to 75 years) with refractory epilepsy
Interventions Yoga treatment (Restorative Yoga).
Outcomes This trial will determine the following:
Primary Outcome Measures: Change in Neurological Disorders Depression Inventory for Epilepsy (NDDI-
E) [Time Frame: Change fromWeek 4 to Week 12]. The NDDI-E is a 6-item questionnaire. Scores for each
question range from 1 (never) to 4 (all the time). There is a maximum score of 24. The higher the score the
more severe the depression.
Secondary OutcomeMeasures: Change in Generalized Anxiety Disorder 7-item (GAD-7) scale [Time Frame:
Change from Week 4 to Week 12]. The GAD-7 is a 7-item questionnaire. Scores for each question range
from 0 (not at all) to 3 (nearly every day). There is a maximum score of 21. The higher the score the more
severe the anxiety. A score over 15 represents severe anxiety. A score under 10 may indicate GAD and would
prompt further examination.
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NCT02950636 2016 (Continued)
Change in Quality of Life in Epilepsy-Patient-Weighted (QOLIE-31-p) [Time Frame: Change from Baseline
to Week 12]. The QOLIE-31-p is a 38-item questionnaire. Scores range from 0 to 100. Higher scores relate
to higher distress.
Frequency of seizures [Time Frame: Week 12]. Count of seizures in study subjects
Starting date December 2016
Contact information Dr. Catherine Lauridsen, University of Kansas Medical Center, USA, clauridsen@kumc.edu
Notes
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D A T A A N D A N A L Y S E S
Comparison 1. Yoga versus no yoga
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Seizures six months after
treatment
1 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Seizure free (yoga versus
sham yoga)
1 20 Odds Ratio (M-H, Fixed, 95% CI) 14.54 [0.67, 316.69]
1.2 Seizure free (yoga versus
none)
1 22 Odds Ratio (M-H, Fixed, 95% CI) 17.31 [0.80, 373.45]
2 Seizure frequency (number per
month)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
2.1 Seizure frequency (yoga
versus sham yoga)
1 20 Mean Difference (IV, Fixed, 95% CI) -2.1 [-3.15, -1.05]
2.2 Seizure frequency (yoga
versus none)
1 22 Mean Difference (IV, Fixed, 95% CI) -1.10 [-1.80, -0.40]
3 Greater than 50% reduction in
seizure frequency - six months
1 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
3.1 Greater than 50%
reduction in seizure frequency
(yoga versus sham yoga)
1 20 Odds Ratio (M-H, Fixed, 95% CI) 81.00 [4.36, 1504.
46]
3.2 Greater than 50%
reduction in seizure frequency
(yoga versus none)
1 22 Odds Ratio (M-H, Fixed, 95% CI) 158.33 [5.78, 4335.
63]
4 Greater than 50% reduction in
seizure duration - six months
1 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
4.1 Greater than 50%
reduction in seizure duration
(yoga versus sham yoga )
1 20 Odds Ratio (M-H, Fixed, 95% CI) 45.0 [2.01, 1006.75]
4.2 Greater than 50%
reduction in seizure duration
(yoga versus none)
1 22 Odds Ratio (M-H, Fixed, 95% CI) 53.57 [2.42, 1187.
26]
Comparison 2. Yoga versus Acceptance Commitment Therapy (ACT)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Seizure free at 1 year follow-up 1 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
2 50% or greater reduction in
seizure frequency
1 18 Odds Ratio (M-H, Fixed, 95% CI) 0.78 [0.04, 14.75]
3 50% or greater reduction in
seizure duration
1 18 Odds Ratio (M-H, Fixed, 95% CI) 0.67 [0.10, 4.35]
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Analysis 1.1. Comparison 1 Yoga versus no yoga, Outcome 1 Seizures six months after treatment.
Review: Yoga for epilepsy
Comparison: 1 Yoga versus no yoga
Outcome: 1 Seizures six months after treatment
Study or subgroup Yoga Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Seizure free (yoga versus sham yoga)
Panjwani 1996 4/10 0/10 100.0 % 14.54 [ 0.67, 316.69 ]
Subtotal (95% CI) 10 10 100.0 % 14.54 [ 0.67, 316.69 ]
Total events: 4 (Yoga), 0 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.70 (P = 0.089)
2 Seizure free (yoga versus none)
Panjwani 1996 4/10 0/12 100.0 % 17.31 [ 0.80, 373.45 ]
Subtotal (95% CI) 10 12 100.0 % 17.31 [ 0.80, 373.45 ]
Total events: 4 (Yoga), 0 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.82 (P = 0.069)
0.002 0.1 1 10 500
Favours Controls Favours Yoga
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Analysis 1.2. Comparison 1 Yoga versus no yoga, Outcome 2 Seizure frequency (number per month).
Review: Yoga for epilepsy
Comparison: 1 Yoga versus no yoga
Outcome: 2 Seizure frequency (number per month)
Study or subgroup Yoga Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Seizure frequency (yoga versus sham yoga)
Panjwani 1996 10 0.5 (0.63) 10 2.6 (1.58) 100.0 % -2.10 [ -3.15, -1.05 ]
Subtotal (95% CI) 10 10 100.0 % -2.10 [ -3.15, -1.05 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.90 (P = 0.000095)
2 Seizure frequency (yoga versus none)
Panjwani 1996 10 0.5 (0.63) 12 1.6 (1.03) 100.0 % -1.10 [ -1.80, -0.40 ]
Subtotal (95% CI) 10 12 100.0 % -1.10 [ -1.80, -0.40 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.07 (P = 0.0021)
-10 -5 0 5 10
Yoga CTL
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Analysis 1.3. Comparison 1 Yoga versus no yoga, Outcome 3 Greater than 50% reduction in seizure
frequency - six months.
Review: Yoga for epilepsy
Comparison: 1 Yoga versus no yoga
Outcome: 3 Greater than 50% reduction in seizure frequency - six months
Study or subgroup Yoga Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Greater than 50% reduction in seizure frequency (yoga versus sham yoga)
Panjwani 1996 9/10 1/10 100.0 % 81.00 [ 4.36, 1504.46 ]
Subtotal (95% CI) 10 10 100.0 % 81.00 [ 4.36, 1504.46 ]
Total events: 9 (Yoga), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.95 (P = 0.0032)
2 Greater than 50% reduction in seizure frequency (yoga versus none)
Panjwani 1996 9/10 0/12 100.0 % 158.33 [ 5.78, 4335.63 ]
Subtotal (95% CI) 10 12 100.0 % 158.33 [ 5.78, 4335.63 ]
Total events: 9 (Yoga), 0 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 3.00 (P = 0.0027)
0.001 0.01 0.1 1 10 100 1000
Favours controls Favours yoga
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Analysis 1.4. Comparison 1 Yoga versus no yoga, Outcome 4 Greater than 50% reduction in seizure
duration - six months.
Review: Yoga for epilepsy
Comparison: 1 Yoga versus no yoga
Outcome: 4 Greater than 50% reduction in seizure duration - six months
Study or subgroup Yoga Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Greater than 50% reduction in seizure duration (yoga versus sham yoga )
Panjwani 1996 7/10 0/10 100.0 % 45.00 [ 2.01, 1006.75 ]
Subtotal (95% CI) 10 10 100.0 % 45.00 [ 2.01, 1006.75 ]
Total events: 7 (Yoga), 0 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.40 (P = 0.016)
2 Greater than 50% reduction in seizure duration (yoga versus none)
Panjwani 1996 7/10 0/12 100.0 % 53.57 [ 2.42, 1187.26 ]
Subtotal (95% CI) 10 12 100.0 % 53.57 [ 2.42, 1187.26 ]
Total events: 7 (Yoga), 0 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.52 (P = 0.012)
0.001 0.01 0.1 1 10 100 1000
Favours controls Favours yoga
Analysis 2.1. Comparison 2 Yoga versus Acceptance Commitment Therapy (ACT), Outcome 1 Seizure free
at 1 year follow-up.
Review: Yoga for epilepsy
Comparison: 2 Yoga versus Acceptance Commitment Therapy (ACT)
Outcome: 1 Seizure free at 1 year follow-up
Study or subgroup Yoga ACT Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lundgren 2008 4/8 5/10 1.00 [ 0.16, 6.42 ]
0.01 0.1 1 10 100
Favours ACT Favours Yoga
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Analysis 2.2. Comparison 2 Yoga versus Acceptance Commitment Therapy (ACT), Outcome 2 50% or
greater reduction in seizure frequency.
Review: Yoga for epilepsy
Comparison: 2 Yoga versus Acceptance Commitment Therapy (ACT)
Outcome: 2 50% or greater reduction in seizure frequency
Study or subgroup Yoga ACT Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lundgren 2008 7/8 9/10 100.0 % 0.78 [ 0.04, 14.75 ]
Total (95% CI) 8 10 100.0 % 0.78 [ 0.04, 14.75 ]
Total events: 7 (Yoga), 9 (ACT)
Heterogeneity: not applicable
Test for overall effect: Z = 0.17 (P = 0.87)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours ACT Favours Yoga
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Analysis 2.3. Comparison 2 Yoga versus Acceptance Commitment Therapy (ACT), Outcome 3 50% or
greater reduction in seizure duration.
Review: Yoga for epilepsy
Comparison: 2 Yoga versus Acceptance Commitment Therapy (ACT)
Outcome: 3 50% or greater reduction in seizure duration
Study or subgroup Yoga ACT Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lundgren 2008 4/8 6/10 100.0 % 0.67 [ 0.10, 4.35 ]
Total (95% CI) 8 10 100.0 % 0.67 [ 0.10, 4.35 ]
Total events: 4 (Yoga), 6 (ACT)
Heterogeneity: not applicable
Test for overall effect: Z = 0.42 (P = 0.67)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours ACT Favours Yoga
A D D I T I O N A L T A B L E S
Table 1. Number of seizures per month (mean (SD))
Group I Group II Group III
Baseline 3.2 (1.89) 3.0 (2.21) 1.7 (1.03)
After six months 0.5 (0.63) 2.6 (1.58) 1.6 (1.03)
These data are from the Panjwani 1996 trial.
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A P P E N D I C E S
Appendix 1. Epilepsy Specialized Register search strategy
1. yoga or relaxation or meditation or pranayama or asanas
2. >26/03/2015:CRSCREATED
3. #1 AND #2
Appendix 2. CENTRAL search strategy
#1 MeSH descriptor: [Yoga] explode all trees
#2 MeSH descriptor: [Relaxation Therapy] explode all trees
#3 yoga or meditation or pranayama or asanas
#4 relax* near/3 (therap* or treat*):ti,ab,kw (Word variations have been searched)
#5 #1 or #2 or #3 or #4
#6 (epilep* or seizure* or convuls*):ti,ab,kw (Word variations have been searched)
#7 MeSH descriptor: [Epilepsy] explode all trees
#8 MeSH descriptor: [Seizures] explode all trees
#9 (#6 or #7 or #8) in Trials
#10 #5 and #9
Appendix 3. MEDLINE (Ovid) 1946- search strategy
1. exp Yoga/
2. exp Relaxation Therapy/
3. (yoga or meditation or pranayama or asanas).tw.
4. (relax$ adj3 (therap$ or treat$)).tw.
5. 1 or 2 or 3 or 4
6. exp Epilepsy/
7. exp Seizures/
8. (epilep$ or seizure$ or convuls$).tw.
9. 6 or 7 or 8
10. exp *Pre-Eclampsia/ or exp *Eclampsia/
11. 9 not 10
12. (randomized controlled trial or controlled clinical trial or pragmatic clinical trial).pt. or (randomi?ed or placebo or randomly).ab.
13. clinical trials as topic.sh.
14. trial.ti.
15. 12 or 13 or 14
16. exp animals/ not humans.sh.
17. 15 not 16
18. 5 and 11 and 17
19. remove duplicates from 18
20. limit 19 to ed=20150326-20170103
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Appendix 4. ClinicalTrials.gov search strategy
(yoga OR meditation OR pranayama OR asanas OR “relaxation therapy”) AND epilepsy | Studies received on or after 03/26/2015
Appendix 5. WHO International Clinical Trials Registry Platform (ICTRP) search strategy
yoga AND epilepsy NOT NCT*
WH A T ’ S N E W
Date Event Description
3 January 2017 New citation required but conclusions have not changed Conclusions are unchanged.
3 January 2017 New search has been performed Searcheswere updated on3 January 2017; nonew studies
were identified
H I S T O R Y
Protocol first published: Issue 1, 1998
Review first published: Issue 3, 1999
Date Event Description
26 March 2015 New citation required but conclusions have not
changed
Conclusions are unchanged.
26 March 2015 New search has been performed Searches were updated on 9 January 2014; no new stud-
ies were identified. Pre-publication searches were car-
ried out on 26 March 2015; again no new studies were
identified
16 May 2011 New search has been performed Searches updated 16 May 2011; no new studies identi-
fied.
One study earlier included as awaiting assessment has
been added as an excluded study (Sathyaprabha 2005).
24 October 2008 Amended Search strategy amended to comply with RevMan 5.
21 August 2008 Amended Converted to new review format.
31 August 2006 New search has been performed Searches updated 1 September 2006. Two new studies
found. These studies have been assessed, one has been
added to the excluded studies section (Sathyaprabha
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2005) and one has been added to the awaiting assess-
ment section (Dahl 2005).
C O N T R I B U T I O N S O F A U T H O R S
Sridharan Ramaratnam and Kalpana Sridharan participated in the data search and assessed studies for eligibility, extracted data and
assessed risk of bias. Mariangela Panebianco was responsible for writing this update and completed data extraction and risk of bias
assessments.
D E C L A R A T I O N S O F I N T E R E S T
MP: none known.
KS: none known.
SR: none known.
S O U R C E S O F S U P P O R T
Internal sources
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External sources
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This review was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Epilepsy Group.
The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews
Programme, NIHR, NHS or the Department of Health.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
None stated.
I N D E X T E R M S
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Medical Subject Headings (MeSH)
∗Yoga; Acceptance and Commitment Therapy; Drug Resistant Epilepsy [etiology; ∗therapy]; Quality of Life; Randomized Controlled
Trials as Topic; Seizures [therapy]; Stress, Psychological [complications; therapy]
MeSH check words
Adult; Humans
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